Cytokinetics CYTK Total Revenue
Total Revenue at other companies
Segments
By product
See fullOther financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's total revenue?
- Cytokinetics (CYTK) reported total revenue of $19.36M in Q1 2026.
- How has Cytokinetics's total revenue changed year-over-year?
- Cytokinetics's total revenue increased by 1125.8% year-over-year, from $1.58M to $19.36M.
- What is the long-term trend for Cytokinetics's total revenue?
- Over 4 years (2021 to 2025), Cytokinetics's total revenue has grown at a 5.7% compound annual growth rate (CAGR), from $70.43M to $88.04M.
- What does total revenue mean?
- The total amount of money generated by business operations before any expenses are deducted.
- How do you interpret total revenue?
- An increase indicates growing market adoption or successful commercialization, while a decrease may signal market saturation or competitive pressure.
- How does total revenue compare across companies?
- Standard across all industries; biotech firms often show lower revenue during clinical development phases compared to commercial-stage peers.